← Evidence map

ReviewActa pharmaceutica Sinica. B2017

Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy.

Wennan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

70 papers cite itlatest 60 shown

2017
…
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28119806